Significant upregulation of TCP1, CCT2/3/5/6A/8 levels have been found in a variety of cancers, with CCT3/6A/8 the best studied in HCC, while there are few studies on CCT4/5/7. This evidence concerns the gene CCT4 and hepatocellular carcinoma.